Systems and Methods for Drug Interaction Analysis
Summary
The USPTO published Patent Application US20260112508A1 for systems and methods analyzing drug-drug and gene-drug interactions. The disclosed invention utilizes a database comprising genes associated with a plurality of drugs based on clinical relevance, and provides recommendations including alternative drugs when problematic interactions are identified. Inventors: Bill Massey, Christopher Diaz, Nicholas Glimcher. Application No. 19117365 filed October 5, 2023.
“The present disclosure is directed to systems and methods for analyzing drug-drug and gene-drug interactions for a user and providing recommendations accordingly.”
About this source
GovPing monitors USPTO Patent Applications - Health Informatics (G16H) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 137 changes logged to date.
What changed
The USPTO published Patent Application US20260112508A1, a health informatics patent application disclosing systems and methods for analyzing drug-drug and gene-drug interactions. The invention utilizes a database linking genes to drugs based on clinical relevance and can recommend alternative drugs when problematic interactions are identified for a user.
Pharmaceutical manufacturers and healthcare technology developers should monitor this filing as it may indicate emerging patent claims in the drug interaction analysis space. Healthcare providers utilizing clinical decision support systems may wish to review any future granted claims for potential licensing or design-around considerations.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYSTEMS AND METHODS FOR DRUG INTERACTION ANALYSIS
Application US20260112508A1 Kind: A1 Apr 23, 2026
Inventors
Bill Massey, Christopher Diaz, Nicholas Glimcher
Abstract
The present disclosure is directed to systems and methods for analyzing drug-drug and gene-drug interactions for a user and providing recommendations accordingly. The systems and methods can utilize a database comprising a list of genes are associated with a plurality of drugs based on clinical relevance of the gene to the actions of the plurality of drugs. The systems and methods can include recommending alternative drugs to users based on any identified problematic drug-drug or gene-drug interactions.
CPC Classifications
G16H 70/40 G16B 20/20 G16H 15/00
Filing Date
2023-10-05
Application No.
19117365
Related changes
Get daily alerts for USPTO Patent Applications - Health Informatics (G16H)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Health Informatics (G16H) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.